Rosuvastatin treatment reverses impaired coronary artery vasodilation in fructose-fed, insulin-resistant rats

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 287, Issue 1 56-1, 2004, Pages

  Miller, Allison W ^a,b   Tulbert, Christina D ^a   Busija, David W ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Calcium dependent potassium channels; Coronary arteries; Fructose fed rat; Insulin resistance

Indexed keywords

FRUCTOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; PLACEBO; POTASSIUM CHANNEL; ROSUVASTATIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BLOOD VESSEL REACTIVITY; CALCIUM TRANSPORT; CARBOHYDRATE INTAKE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; DOSE TIME EFFECT RELATION; IN VITRO STUDY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; NONHUMAN; POTASSIUM TRANSPORT; PRIORITY JOURNAL; RANDOMIZATION; RAT; REGULATORY MECHANISM; VASODILATATION;

ACETYLCHOLINE; ANIMALS; CHOLESTEROL; CORONARY CIRCULATION; CORONARY VESSELS; FLUOROBENZENES; FRUCTOSE; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; LIPIDS; MALE; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; SULFONAMIDES; TRIGLYCERIDES; VASODILATION; VASODILATOR AGENTS;

EID: 3042738127     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00647.2003     Document Type: Article

References (32)

1. Alvarez de Sotomayor M, Perez-Guerrero C, Herrera MD, Marhuenda E. Effects of chronic treatment with simvastatin on endothelial dysfunction in spontaneously hypertensive rats. J Hypertens 17: 769-776, 1999.
2. + ATPase on EDHF relaxations in the rat hepatic artery. Br J Pharmacol 129: 1490-1496, 2000.
3. Avogaro A, Miola M, Favaro A, Pacini G, Manzato E, Zambon S, Sacerdoti D, de Kreutzenberg S, Piliego T, Tiengo A, and Del Prato S. Gemfibrozil improves insulin sensitivity and flow-mediated vasodilation in type 2 diabetic patients. Eur J Clin Invest 31: 603-609, 2001.
4. Bellosta S, Rerri N, Bernini F, Paoletti R, and Corsini A. Non-lipid related effects of statins. Ann Med 32: 164-176, 2000.
5. Delbosc S, Morena M, Djouad F, Ledoucen Descomps B, and Cristol JP. Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, are able to reduce superoxide anion production by NADPH oxidase in THP-1-derived monocytes. J Cardiovasc Pharmacol 40: 611-617, 2002.
6. De Man FH, Weverling-Rijnsburger WE, van der Laarse A, Smelt AHM, Jukema JW, and Baauw GJ. Not acute but chronic hypertriglyceridemia is associated with impaired endothelium-dependent vasodilation: reversal after lipid-lowering therapy by atorvastatin. Arterioscler Thromb Vasc Biol 20: 744-750, 2000.
7. Després JP, Lamarche B, Mauriège P, Cantin B, Dagenais GR, Moorjani S, and Lupien PJ. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334: 952-957, 1996.
8. Ca) currents are reduced in microvascular smooth muscle cells from insulin-resistant rats. Am J Physiol Heart Circ Physiol 282: H908-H917, 2002.
9. Doughty JM, Plane F, and Langton PD. Charybdotoxin and apamin block EDHF in rat mesentery if selectively applied to the endothelium. Am J Physiol Heart Circ Physiol 276: H1107-H1112, 1999.
10. Dumont AS, Hyndman E, Dumont RJ, Fedak PM, Kassell NF, Sutherland GR, and Verma S. Improvement of endothelial function in insulin-resistant carotid arteries treated with pravastatin. J Neurosurg 95: 466-471, 2001.
11. Erdos B, Miller AW, and Busija DW. Alterations in calcium-activate and ATP-dependent potassium function in cerebral arteries of insulin-resistant rats. Am J Physiol Heart Circ Physiol 283: H2472-H2477, 2002.
12. Erdos B, Miller AW, and Busija DW. Impaired endothelium mediated relaxation in isolated cerebral arteries from insulin resistant rats. Am J Physiol Heart Circ Physiol 282: H2060-H2065, 2002.
13. Fontbonne A, Charles MA, Thibult N, Richard JL, Claude JR, Warnet JM, Rosselin GE, and Eschwège E. Hyperinsulinemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up. Diabetologia 34: 356-361, 1991.
14. 4S Investigators. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344: 1383-1389, 1994.
15. Goldberg RB, Mellies MJ, Sacks FM, Moye LA, Howard BV, Howard WJ, Davis BR, Cole TG, Pfeffer MA, and Braunwald E. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. CARE Investig Circ 98: 2513-2519, 1998.
16. Haffner SM, Alexander CM, Cook TJ, Boccuzzi SJ, Musliner TA, Pedersen TR, Kjekshus J, and Pyorala K. Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study. Arch Intern Med 159: 2661-2667, 1999.
17. Hernandez-Perera O, Perez-Sala D, Navarro-Antolin J, Sanchez-Pascuala R, Hernandez G, Diaz C, and Lamas S. Effects of the HMG CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J Clin Invest 101: 2711-2719, 1998.
18. Howard G, O'Leary DH, Zaccaro D, Haffner S, Rewers M, Hamman R, Selby JV, Saad MF, Savage P, and Bergman R (for the IRAS Investigators). Insulin sensitivity and atherosclerosis. Circulation 93: 1809-1817, 1996.
19. Hwang IS, Ho H, Hoffman B, and Reaven GM. Fructose-induced insulin resistance, and hypertension in rats. Hypertension 10: 512-516, 1987.
20. Katakam PVG, Ujhelyi MR, Hoenig ME, and Miller AW. Endothelial dysfunction precedes hypertension in diet-induced insulin resistance. Am J Physiol Regul Integr Comp Physiol 275: R788-R792, 1998.
21. Katakam PVG, Ujhelyi MR, and Miller AW. EDHF mediated relaxation is impaired in fructose fed rats. J Cardiovasc Pharmacol 34: 461-467, 1999.
22. Koh KK. Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability. Cardiovasc Res 47: 648-657, 2000.
23. Kusterer K, Pohl T, Fortmeyer HP, Marz W, Scharnagl H, Oldenburg A, Angermuller S, Fleming I, Usadel KH, and Busse R. Chronic selective hypertriglyceridemia impairs endothelium dependent vasodilation in rats. Cardiovasc Res 42: 783-793, 1999.
24. Laufs U, LaFata V, Plutzky J, and Liao JK. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97: 1129-1135, 1998.
25. Lemaitre RN, Psaty BM, Heckbert SR, Kronmal RA, Newman AB, and Burke G. Therapy with hydroxymethylglutaryl coenzyme A reductase inhibitors and associated risk of incident cardiovascular events in older adults: evidence from the cardiovascular health study. Arch Intern Med 162: 1395-1400, 2002.
26. Lind L, Berne C, and Lithell H. Prevalence of insulin resistance in essential hypertension. J Hypertens 13: 1457-1462, 1995.
27. + channel activity in smooth muscle of human coronary. Circ Res 91: 1070-1076, 2002.
28. Miller AW, Katakam PVG, and Ujhelyi MR. Impaired endothelium mediated relaxation in coronary arteries of insulin resistant rats. J Vasc Res 36: 385-392, 1999.
29. Miller AW, Dimitropoulou C, Han G, White RE, Busija DW, and Carrier GO. Epoxyeicosatrienoic acid-induced relaxation is impaired in insulin resistance. Am J Physiol Heart Circ Physiol 281: H1524-H1531, 2001.
30. Shinozake K, Okamura T, Nishio Y, Kashiwagi A, Kikkawa R, and Toda N. Evaluation of endothelial free radical release by vascular tension responses in insulin-resistant rat aorta. Eur J Pharmacol 394: 295-299, 2000.
31. 2- imbalance in insulin resistant rat aorta. Diabetes 48: 2437-2445, 1999.
32. + channels in smooth muscle. J Gen Physiol 110: 35-44, 1997.